Terry Chase consults and leads Sponsored Research at Celltex Therapeutics Corporation. She consults for the Texas A&M Clean Energy Incubator. She is a member of the National Instructor team at the NSF I-Corps program. She’s an Advisor for EVO Conversion Systems. She serves as interim executive for several companies.
She has experience leading companies through transition, funding and growth. She has led and invested across a variety of industries including, Biotechnology, Clean Energy, IT, Pharma & Advanced Manufacturing as well as other specialty industries. She is skilled in assessing assets, intellectual property and products, finding opportunities for stability and returns, managing operations and finances, performing creditor negotiation, and leading resolution of conflict and closing sales and exits.
Chase was Director of the $500M Texas Emerging Technology Fund. She negotiated over $25M in returns and was credited with being the employee who generated the most returns for the office. She co-founded a women’s business accelerator. She has launched or helped launch over 40 startups—many led by women. She serves on the advisory committee for venture accelerator, Springboard Enterprises.
Previously, Chase was an entrepreneur spinning out university technologies into successful products and companies. She founded an award-winning bioprocessing startup, which was named one of Fortune Magazine’s Coolest Companies. She served on the Board of FujiFilm Diosynth Biotechnologies Texas for the State of Texas.
The Austin American Statesman named her one of Austin’s most social citizens and the Austin Business Journal named her one of the top 20 politically-minded Austinites to know.
She holds master’s degrees in Technology Management and in Finance and Accounting and a degree in Microbiology.